Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Preferred Shares: 2013-2024

Historic Preferred Shares for Iovance Biotherapeutics (IOVA) over the last 6 years, with Dec 2024 value amounting to $3,000.

  • Iovance Biotherapeutics' Preferred Shares was N/A to $2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2,000, marking a year-over-year change of. This contributed to the annual value of $3,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Iovance Biotherapeutics' Preferred Shares amounted to $3,000 in FY2024, which was down 0.00% from $3,000 recorded in FY2023.
  • Over the past 5 years, Iovance Biotherapeutics' Preferred Shares peaked at $3,000 during FY2023, and registered a low of $3,000 during FY2023.
  • In the last 2 years, Iovance Biotherapeutics' Preferred Shares had a median value of $3,000 in 2024 and averaged $3,000.